ENSC

Conviction 49HealthcareScan · Mon, Aug 10, 2026

ENSC$0.4340-16.57%

ResistanceSupportVol 14

Vol MA14 59.12M

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest -33.33%· 2 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Ensysce Biosciences, Inc.Pharmaceutical Preparationswww.ensysce.com ↗

Price0.4340

Change-16.57%

Gap-11.65%

Rel volume0.00×

Avg volume42.46M

Avg $ vol19.15M

SMA 200.3149

SMA 500.2911

SMA 2000.7600

Price vs 50+49.09%

Price vs 200-42.90%

MA stackmixed

50/200 cross—

Supertrendup · 0.4102

RSI (14)64

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D26 / 34

ADX (14)32

+DI / −DI58 / 13

RSI divergence—

MACD divergence—

ATR %+19.39%

ADR %16.07%

52w high2.57

52w low0.2510

From 52w high-83.11%

Above 52w low+72.91%

New 52w highNo

SqueezeOff

Bollinger width105.66%

%B0.86

Donchian pos26.55%

Donchian high0.9790

Donchian low0.2370

AVWAP (52w high)0.5448

vs AVWAP high-20.34%

AVWAP (52w low)0.5200

vs AVWAP low-16.54%

OBV trendUp

Chaikin MF (20)-0.49

Today vs 20d0.00×

Avg vol (14d)59.12M

Avg vol (20d)42.46M

Avg $ vol (20d)19.15M

Market cap6.38M

RS 3m (vs SPY)+34.90%

RS 6m (vs SPY)-0.78%

RS line new highNo

Trend template3/8

Technical rank43.3

1 week+54.94%

1 month+60.80%

3 months+23.93%

6 months-5.94%

1 year-79.13%

YTD-53.83%

P/E2.65

P/B-18.75

P/S1.26

P/FCF-0.80

EPS-3.98

Div yield—

ROE-707.12%

ROA110.92%

Debt/Eq—

Current0.71

EV/EBITDA—

Gross margin—

Net margin47.46%

Rev growth-2.75%

EPS growth557.05%

Price target—

Target upside—

Analyst rating—

Institutional3.41%

Ent. value5.63M

Revenue961K

Net income-17.16M

Gross profit—

Free cash flow-7.93M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out15.37M

Employees10

ListedThu, Jul 1, 2021

Free float9.16M

Float %98.8%

Short interest403.33K

Days to cover0.2d

Short volume44.4%

Squeeze score13 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.52 vs −$0.73

Last surprise+28.8% beat

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank43.3 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.6530

Support0.2385

Days since event—

Candle confirm—

News sentiment—

Financials as of Thu, Sep 30, 2021 · quarterly.

Congress activity

Disclosed STOCK Act trades in ENSC

All disclosures →

No recent disclosed trades by Congress in ENSC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ENSC

No recent insider (Form 4) filings in ENSC. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ENSC · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.